Prognostic significance of dynamic evaluation of C-peptide level in prediction type 1 diabetes mellitus in children
Problems of Endocrinology · 2026-05-20 · 72 (2) · 78-85
DOI: 10.14341/probl13645 ↗At a glance
Multizentrische Studie in Problems of Endocrinology, published online on 2026-05-20. Written by K G Korneva and 4 co-authors. Institution: Privolzhsky Research Medical University. Major MEDLINE topics: Diabetes Mellitus, Type 1, C-Peptide. 17 references. The full text is freely available in PubMed Central.
Topics: Diabetes mellitus, Kinderkrankenpflege
Abstract (original language)
BACKGROUND : Type 1 diabetes mellitus (T1DM) is a chronic progressive autoimmune disease characterized by destruction of pancreatic betta cells leading to insulin deficiency, measured by C-peptide testing. C-peptide secretion has been studied in diagnostic, prognostic and therapeutic aspects in patients with already manifested T1DM. Insulin secretion assessed by the level of C-peptide at the preclinical stage remains under-studied. AIM : The aim of the study was to assess the possibility of predicting the development of T1DM in healthy siblings based on dynamic measurements of C-peptide concentration. MATERIALS AND METHODS : A multicenter prospective longitudinal study involving 532 individuals was conducted. Median follow-up duration was 5.6 years. Group 1 (n=325) included children aged 0–18 years with newly diagnosed T1DM; group 2 (n=201) consisted of healthy brothers and sisters (siblings) who did not develop T1DM until the end of the study; group 3 (n=6) comprised healthy siblings who developed T1DM before the study completion. All participants underwent dynamic testing of blood analysis for C-peptide using solid-phase chemiluminescent immunoassay. RESULTS : In groups 1 and 3, the actual median concentration of baseline C-peptide was below reference values: 0.31 ng/mL [95% CI 0.10–1.39] and 0.56 ng/mL [95% CI 0.32–0.85], respectively. In group 2, it corresponded to the lower limit of reference values: 0.88 ng/mL [95% CI 0.28–2.69]. The observed differences were statistically significant between groups 1 and 2 (χ 2 =168.29, df=1, p < 0.001) and between groups 2 and 3 (χ 2 =4.2292, df=1, p=0.040). Regression modeling revealed a nonlinear positive relationship between C-peptide concentration and age. At any age category, the median initial C-peptide concentration in groups 1 and 3 was lower than that in group 2 above the average level ("intercept") characteristic for the cohort of specific age. The association between C-peptide concentration and time since observation onset was statistically significant (p < 0.05) and bidirectional: over time, concentrations decreased in groups 1 and 3 and increased in group 2. CONCLUSION : Measurement of baseline C-peptide levels followed by dynamic monitoring may serve as an additional screening tool for predicting the risk of T1DM development in healthy siblings.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Privolzhsky Research Medical University.
- Penza state University.
- Endocrinology Research Centre.
Cite
APA
Korneva, K. G., Chichevatov, D. A., Bezlepkina, O. B., Strongin, L. G., & Zagainov, V. E. (2026). Prognostic significance of dynamic evaluation of C-peptide level in prediction type 1 diabetes mellitus in children. Problems of Endocrinology, 72(2), 78-85. https://doi.org/10.14341/probl13645
Vancouver
Korneva KG, Chichevatov DA, Bezlepkina OB, Strongin LG, Zagainov VE. Prognostic significance of dynamic evaluation of C-peptide level in prediction type 1 diabetes mellitus in children. Problems of Endocrinology. 2026;72(2):78-85. doi:10.14341/probl13645
BibTeX
@article{Korneva2026,
author = {Korneva, K G and Chichevatov, D A and Bezlepkina, O B and Strongin, L G and Zagainov, V E},
title = {Prognostic significance of dynamic evaluation of C-peptide level in prediction type 1 diabetes mellitus in children},
journal = {Problems of Endocrinology},
year = {2026},
volume = {72},
number = {2},
pages = {78--85},
doi = {10.14341/probl13645}
}
EUVIMED